X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (66) 66
male (51) 51
middle aged (47) 47
female (45) 45
adult (39) 39
aged (27) 27
risk factors (27) 27
cardiac & cardiovascular systems (26) 26
angioplasty (18) 18
cohort studies (15) 15
follow-up studies (14) 14
prospective studies (14) 14
echocardiography (13) 13
massachusetts - epidemiology (13) 13
medicine, general & internal (13) 13
regression analysis (13) 13
risk (13) 13
sex factors (13) 13
age factors (12) 12
electrocardiography (12) 12
clinical trials (11) 11
coronary disease - epidemiology (11) 11
statistics & probability (11) 11
cholesterol - blood (10) 10
oncology (10) 10
abciximab (9) 9
disease (9) 9
peripheral vascular disease (9) 9
prevalence (9) 9
cholesterol (8) 8
hematology (8) 8
index medicus (8) 8
massachusetts (8) 8
medical research (8) 8
models, statistical (8) 8
mortality (8) 8
prognosis (8) 8
survival analysis (8) 8
adaptive design (7) 7
blood pressure (7) 7
cardiovascular system (7) 7
hypertrophy (7) 7
incidence (7) 7
integrin (7) 7
physiological aspects (7) 7
aged, 80 and over (6) 6
cardiomegaly - epidemiology (6) 6
coronary disease - mortality (6) 6
coronary heart disease (6) 6
hypertension (6) 6
logistic models (6) 6
multivariate analysis (6) 6
sample size (6) 6
smoking (6) 6
therapy (6) 6
time factors (6) 6
antibodies, monoclonal - therapeutic use (5) 5
body mass index (5) 5
cardiovascular disease (5) 5
cholesterol, hdl - blood (5) 5
clinical-trials (5) 5
confidence intervals (5) 5
designs (5) 5
immunoglobulin fab fragments - therapeutic use (5) 5
mathematical & computational biology (5) 5
measurement (5) 5
obesity (5) 5
pharmacology & pharmacy (5) 5
platelets (5) 5
population (5) 5
prevention (5) 5
probability (5) 5
randomized trial (5) 5
statistics (5) 5
transluminal angioplasty (5) 5
treatment outcome (5) 5
acute myocardial-infarction (4) 4
alcohol drinking (4) 4
aspirin (4) 4
blood cholesterol (4) 4
cardiomegaly - complications (4) 4
coronary disease - etiology (4) 4
criteria (4) 4
cross-sectional studies (4) 4
epidemiology (4) 4
exercise (4) 4
health aspects (4) 4
heart ventricle, left (4) 4
heart ventricles - diagnostic imaging (4) 4
heparin (4) 4
longitudinal studies (4) 4
medicine, research & experimental (4) 4
men (4) 4
monoclonal antibodies (4) 4
myocardial-infarction (4) 4
obesity - complications (4) 4
platelet glycoprotein gpiib-iiia complex - antagonists & inhibitors (4) 4
proportional hazards models (4) 4
public, environmental & occupational health (4) 4
stents (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Statistics in Medicine, ISSN 0277-6715, 01/2015, Volume 34, Issue 1, pp. 27 - 38
Journal Article
Statistics in Biopharmaceutical Research, ISSN 1946-6315, 10/2015, Volume 7, Issue 4, pp. 357 - 358
Journal Article
Statistics in Biopharmaceutical Research, 10/2015, Volume 7, Issue 4, pp. 357 - 358
We congratulate the authors on their comments on innovative approaches to drug development that fall out of the traditional mold and may result in more quickly... 
Journal Article
Statistics in Biopharmaceutical Research, 10/2015, Volume 7, Issue 4, pp. 357 - 358
Journal Article
Statistics in Medicine, ISSN 0277-6715, 02/2010, Volume 29, Issue 3, pp. 321 - 327
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 12/2008, Volume 103, Issue 484, p. 1621
  In group sequential trials, it is important to obtain adequate data to assess overall benefits and risks of an experimental treatment for patients. To... 
Confidence intervals | Research methodology | Clinical trials | Statistics
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2018, Volume 24, Issue 20, pp. 4960 - 4967
Purpose: The purpose of this study was to assess the association of baseline tumor size (BTS) with other baseline clinical factors and outcomes in... 
VERSION | THERAPY | ANTI-PD-1 | ONCOLOGY | IPILIMUMAB | anti–PD-1 | Immunotherapy | prognostic factors
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 12/2018, Volume 24, Issue 23, pp. 5841 - 5849
Purpose: To investigate the relationship of pembrolizumab pharmacokinetics (PK) and overall survival (OS) in patients with advanced melanoma and non-small cell... 
CELL LUNG-CANCER | MELANOMA | ONCOLOGY | METABOLISM | POPULATION PHARMACOKINETICS | PHASE-II | TUMOR SIZE | PREDICT SURVIVAL | IPILIMUMAB | CHEMOTHERAPY
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2017, Volume 35, Issue 7_suppl, pp. 77 - 77
77 Background: Pembrolizumab showed promising activity in patients with advanced non–small cell lung cancer (NSCLC) in the KEYNOTE-001 study (NCT01295827) and... 
Journal Article
Journal of the American Statistical Association, ISSN 0162-1459, 12/2008, Volume 103, Issue 484, pp. 1621 - 1630
Journal Article
Statistics in Medicine, ISSN 0277-6715, 01/2015, Volume 34, Issue 1, pp. 27 - 38
Journal Article
Clinical cancer research : an official journal of the American Association for Cancer Research, ISSN 1078-0432, 12/2018, Volume 24, Issue 23, pp. 6098 - 6098
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 02/2010, Volume 16, Issue 4, pp. 1085 - 1087
Journal Article
JAMA, ISSN 0098-7484, 08/1997, Volume 278, Issue 6, pp. 479 - 484
Context.—Avciximab,lonal antibody fragment against the platelet receptor αllbβ3 integrin, prevents platelet aggregation. A randomized, placebo-controlled study... 
Journal Article
The Lancet, ISSN 0140-6736, 12/1999, Volume 354, Issue 9195, pp. 2019 - 2024
We assessed in a randomised trial the long-term outcomes for potent adjunctive antiplatelet therapy given at the time of coronary stenting. In 63 hospitals in... 
MEDICINE, GENERAL & INTERNAL | INTERVENTIONS | PLACEMENT | TICLOPIDINE | IMPLANTATION | ACUTE MYOCARDIAL-INFARCTION | BALLOON ANGIOPLASTY | ARTERY DISEASE | ASPIRIN | ANTIPLATELET THERAPY | ANTICOAGULATION | Coronary artery bypass | Methods
Journal Article
Cancer Discovery, ISSN 2159-8274, 06/2011, Volume 1, Issue 1, pp. 17 - 20
Successful completion of the Biomarker-integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial, reported in this issue of Cancer... 
GROWTH-FACTOR RECEPTOR | LUNG-CANCER | DESIGN | ONCOLOGY | SENSITIVITY | ANTIBODY | PERSONALIZED MEDICINE | Lung Neoplasms - drug therapy | Humans | Lung Neoplasms - metabolism | Biomarkers, Tumor - metabolism | Female | Male | Molecular Targeted Therapy - methods | Precision Medicine - methods
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.